Common Questions About Spravato Treatment in NYC

Starting a new treatment often comes with many questions. Individuals considering Spravato® (esketamine) treatment frequently want to understand what treatment involves, how it works, and what practical considerations to expect.

For those researching Spravato treatment in NYC, having clear answers to common questions can help reduce uncertainty and support informed decisions.

Below are some of the most frequently asked questions patients have when considering Spravato treatment.

How long does a Spravato session take?

Each session typically lasts about two hours. This includes:

• Preparation and check-in

• Medication administration

• Monitoring period

• Medical clearance before leaving

The observation period is an important part of the treatment process and helps ensure safety.

Patients may also benefit from understanding what to expect from Spravato treatment sessions before beginning care.

How often is Spravato given?

Treatment usually begins with twice-weekly sessions for the first several weeks. Frequency may then decrease depending on response and clinical evaluation.

Some patients transition to:

• Once weekly

• Every other week

• Maintenance scheduling

Treatment plans are individualized based on progress.

Can I drive after Spravato treatment?

No. Patients must arrange transportation home after each session.

Because Spravato can temporarily affect alertness, coordination, and perception, patients should not:

• Drive

• Operate machinery

• Return to demanding work activities

until the following day.

What does Spravato feel like?

Experiences vary from person to person. Some patients describe:

• Mental quieting

• Relaxation

• Altered perception

• Emotional processing

• A floating sensation

• Temporary dissociation

Others experience more subtle effects. Both types of experiences can still be clinically meaningful.

Does insurance cover Spravato treatment?

Many insurance plans cover Spravato when criteria for treatment-resistant depression are met. Coverage depends on individual plans and verification is always required.

Many patients also review the cost of Spravato treatment in NYC when planning care.

Because Spravato is FDA-approved for treatment-resistant depression, it is more commonly covered than ketamine infusions, which are typically off-label.

Do I need to stop my current medications?

Not necessarily. Many patients continue their existing psychiatric medications during Spravato treatment.

Medication decisions are individualized and reviewed during psychiatric evaluation.

How quickly does Spravato work?

Some patients notice early changes within the first few weeks. For others, improvement develops more gradually.

Patients often want to understand how long Spravato takes to work and what treatment progress may look like over time.

Progress is typically evaluated across multiple sessions rather than after a single treatment.

Improvement often first appears in:

• Functioning

• Motivation

• Stress tolerance

• Emotional regulation

rather than immediate mood change.

Is Spravato safe?

Spravato is administered under FDA REMS safety protocols. This requires:

• Treatment in certified medical offices

• Monitoring after dosing

• Ongoing psychiatric evaluation

• Structured safety procedures

These safeguards help maintain appropriate use.

This is part of how Spravato treatment is monitored for safety in a structured medical setting.

Is Spravato addictive?

Spravato is administered in controlled medical settings with monitoring and structured protocols. Careful patient selection and supervision help reduce risks.

Can Spravato be used with therapy?

Yes. Spravato is typically used alongside ongoing psychiatric care and psychotherapy rather than as a stand-alone treatment.

Integrating treatment into broader care often improves outcomes.

What if Spravato does not help?

Response varies. If improvement is limited, clinicians may:

• Adjust frequency

• Re-evaluate treatment goals

• Modify the treatment plan

• Consider additional supports

Ongoing psychiatric evaluation helps guide these decisions.

Patients may also want to understand why some patients do not respond to Spravato and how treatment plans are adjusted.

How long do patients stay on Spravato?

There is no single timeline. Some patients require maintenance treatment while others may reduce frequency over time.

Treatment duration depends on:

• Clinical response

• Stability

• Functional improvement

• Treatment goals

This is determined through ongoing evaluation.

What conditions does Spravato treat?

Spravato is FDA-approved for:

• Treatment-resistant depression

• Major depressive disorder with suicidal thinking (when clinically appropriate)

A psychiatric evaluation determines whether treatment is appropriate.

How do I know if I am a good candidate?

Candidacy depends on:

• Diagnosis

• Treatment history

• Medical safety

• Functional impact of symptoms

• Treatment goals

A consultation helps determine whether Spravato may be appropriate.

You can also learn more about who qualifies for Spravato treatment and how candidacy is evaluated.

Patients also often explore:

• What to expect from Spravato treatment

• Cost of Spravato treatment in NYC

• How long Spravato takes to work

• Who qualifies for Spravato treatment

Considering Spravato Treatment in NYC

For individuals considering Spravato treatment in NYC, understanding practical aspects of treatment can help make the process feel more manageable.

Patients considering Spravato treatment in Midtown Manhattan often look for care that combines medical safety, structured monitoring, and individualized psychiatric oversight.

A consultation can help determine whether Spravato may be appropriate and what treatment may realistically involve.

Final Thoughts

Spravato treatment is best understood as part of a structured psychiatric care plan rather than a stand-alone intervention. Understanding how treatment works, what safety measures are in place, and what progress may look like can help patients approach treatment with greater clarity.

Having questions is normal. Careful evaluation and open discussion help ensure treatment decisions are thoughtful and appropriate.

If you are considering Spravato treatment in NYC, a consultation at Elevate Medical can help determine whether this treatment is appropriate based on your history, symptoms, and treatment goals.

Contact Elevate Medical to schedule a consultation.

Medically reviewed by the Elevate Medical psychiatric team providing Spravato treatment in Midtown Manhattan